Epithelial Hyperplasia

Key points
- Proliferation of epithelial cells lining the terminal duct-lobular unit is known as epithelial hyperplasia.
- Patients with atypical hyperplasia do not present with classical clinical features.
- There are no specific mammographic features associated with hyperplasia, and the most common way to diagnose mammographically is in association with a cluster of microcalcification.
- Microscopic Appearance Epithelial hyperplasia of usual type can occur in any part of the breast glandular structure but predominantly affects the terminal duct-lobular unit.
Proliferation of epithelial cells lining the terminal duct-lobular unit is known as epithelial hyperplasia. The degree of hyperplasia can be graded as mild, moderate or florid. There may be associated atypical features. The significance of atypia is related to the risk of subsequent development of breast cancer. There is a strong interaction with family history and atypical hyperplasia.
Three case control studies have demonstrated a relative risk for breast cancer ranging from 3.7-13 in patients with atypical hyperplasia.
Clinical Features
Patients with atypical hyperplasia do not present with classical clinical features. They can present with a lump or lumpiness or may be noted to have an abnormality on screening mammography.
Radiology
There are no specific mammographic features associated with hyperplasia, and the most common way to diagnose mammographically is in association with a cluster of microcalcification.
Pathology
Microscopic Appearance
Epithelial hyperplasia of usual type can occur in any part of the breast glandular structure but predominantly affects the terminal duct-lobular unit.
Depending on the number of cell layers present, the degree of duct expansion and the presence of secondary lumina, these proliferations can be subdivided into mild, moderate and florid. The cytological inter-relationships of usual-type hyperplasia are haphazard, giving an untidy appearance with irregular and often slit-like secondary lumina where these are present. The cells themselves have regular nuclear chromatin and vary in shape from spindle and elongated to round. An admixture of myoepithelial cells is usually present.
Atypical ductal hyperplasia (ADH) is intermediate between florid epithelial hyperplasia and low-grade ductal carcinoma in situ (DCIS) usually of cribriform type. Thus, at the lower end of the spectrum, ADH includes features of florid epithelial hyperplasia plus small focal areas of more uniform cytology and more even placement of cells. The atypical features give rise to the more rounded, very regular outlines of the secondary lumina characteristic of low-grade DCIS. The cells in ADH also show more nuclear hyperchromasia than those in usual-type epithelial hyperplasia. The distinction of ADH from low-grade DCIS can be extremely difficult and is based on the degree and extent of the atypical features.
Atypical lobular hyperplasia (ALH) is a uniform proliferation of small, monomorphic cells that partially fill most of the acini in one or more lobular units. Some, but not all, of the acinar lumina are obliterated.
Management
Following a pathological diagnosis, the decision to follow up a patient should be based on subsequent risk for breast cancer. Patients with atypical hyperplasia may be considered for entry into breast cancer prevention trials.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsAnti-tumor immunity identified with new ovarian cancer treatment strategy
Few effective treatments have been approved to treat ovarian cancer , the deadliest of all cancers affecting the female reproductive system. Now, new research from The Wistar Institute demonstrates how a drug already in…
27 September 2016
NewsStudy examines survival outcomes after different lung cancer staging methods
In a study appearing in the September 13 issue of JAMA, Jouke T. Annema, M.D., Ph.D., of the Academic Medical Center, Amsterdam, and colleagues examined five-year survival after endosonography vs mediastinoscopy for…
27 September 2016
NewsNew strategy identified for treating acute myeloid leukemia
A multi-institutional academic and industry research team led by investigators from Massachusetts General Hospital (MGH) and the Harvard Stem Cell Institute has identified a promising new approach to the treatment of…






